Literature DB >> 9006351

Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles.

R L Shapiro1, J G Duquette, I Nunes, D F Roses, M N Harris, E L Wilson, D B Rifkin.   

Abstract

Urokinase-type plasminogen activator (uPA) is thought to be an important mediator in the proteolytic degradation of extracellular matrix components observed in a wide variety of normal physiological and pathological conditions. However, the phenotype of a recently developed strain of urokinase-deficient (uPA-/-) mice appears to be normal when maintained under ideal nonstressful conditions. We report an outbreak of botryomycosis, an unusual staphylococcal infection, in a colony of uPA-deficient mice. A detailed histological examination of these uPA-deficient animals also revealed a variety of previously unreported phenotypic abnormalities such as pleuritis and the effacement of lymphoid follicles in the regional lymph nodes and spleen. Additional phenotypic abnormalities such as dystrophic calcifications and rectal prolapse were also observed in the uPA-deficient population. These abnormalities were also noted in ostensibly healthy uPA-deficient animals. Botryomycosis did not affect a colony of wild-type (uPA+/+) animals maintained concurrently under identical conditions in the same room. The peculiar predisposition of the uPA-deficient animals to this rare bacterial infection and the development of phenotypic abnormalities associated with the targeted disruption the uPA gene suggests that uPA contributes significantly to the cutaneous microenvironment and is additional evidence of the extensive involvement of the plasminogen activators in mammalian physiology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006351      PMCID: PMC1858536     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

Review 1.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

2.  Staphylococcal botryomycosis in a specific-pathogen-free mouse colony.

Authors:  F S Shults; P C Estes; J A Franklin; C B Richter
Journal:  Lab Anim Sci       Date:  1973-02

3.  The apparent transmission of staphylococci of human origin to laboratory animals.

Authors:  D K Blackmore; R A Francis
Journal:  J Comp Pathol       Date:  1970-10       Impact factor: 1.311

4.  "Bacterial interference" and staphylococcic colonization in infants and adults.

Authors:  H F Eichenwald; H R Shinefield; M Boris; J C Ribble
Journal:  Ann N Y Acad Sci       Date:  1965-07-23       Impact factor: 5.691

5.  An epidemic of chronic skin ulceration in rats.

Authors:  G W Ash
Journal:  Lab Anim       Date:  1971-04       Impact factor: 2.471

6.  Effects of anti-promoters and strain of mouse on tumor promoter-induced oxidants in murine epidermal cells.

Authors:  S M Fischer; J K Baldwin; L M Adams
Journal:  Carcinogenesis       Date:  1986-06       Impact factor: 4.944

7.  Enhanced release of hydrogen peroxide and metabolites of arachidonic acid by macrophages from SENCAR mice following stimulation with phorbol esters.

Authors:  J G Lewis; D O Adams
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

8.  Development of a new melanoma model in C57BL/6 mice.

Authors:  J Berkelhammer; R W Oxenhandler; R R Hook; J M Hennessy
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

9.  EFFECT OF DIET AND STRAIN DIFFERENCE ON THE VIRULENCE OF STAPHYLOCOCCUS AUREUS FOR MICE.

Authors:  L G NUTINI; N J BERBERICH
Journal:  Appl Microbiol       Date:  1965-07

10.  Immunologic abnormalities in botryomycosis. A case report with review of the literature.

Authors:  R C Brunken; N Lichon-Chao; H van der Broek
Journal:  J Am Acad Dermatol       Date:  1983-09       Impact factor: 11.527

View more
  9 in total

1.  Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.

Authors:  M E Dominiecki; J Weiss
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Design, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor.

Authors:  Fang Wang; W Eric Knabe; Liwei Li; Inha Jo; Timmy Mani; Hartmut Roehm; Kyungsoo Oh; Jing Li; May Khanna; Samy O Meroueh
Journal:  Bioorg Med Chem       Date:  2012-06-12       Impact factor: 3.641

3.  Urothelial function reconsidered: a role in urinary protein secretion.

Authors:  F M Deng; M Ding; R M Lavker; T T Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

4.  Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasis.

Authors:  Fang Wang; Jing Li; Anthony L Sinn; W Eric Knabe; May Khanna; Inha Jo; Jayne M Silver; Kyungsoo Oh; Liwei Li; George E Sandusky; George W Sledge; Harikrishna Nakshatri; David R Jones; Karen E Pollok; Samy O Meroueh
Journal:  J Med Chem       Date:  2011-10-04       Impact factor: 7.446

5.  Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.

Authors:  D H Nguyen; A D Catling; D J Webb; M Sankovic; L A Walker; A V Somlyo; M J Weber; S L Gonias
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

6.  Targeting multiple conformations leads to small molecule inhibitors of the uPAR·uPA protein-protein interaction that block cancer cell invasion.

Authors:  May Khanna; Fang Wang; Inha Jo; W Eric Knabe; Sarah M Wilson; Liwei Li; Khuchtumur Bum-Erdene; Jing Li; George W Sledge; Rajesh Khanna; Samy O Meroueh
Journal:  ACS Chem Biol       Date:  2011-09-29       Impact factor: 5.100

7.  Urokinase-type plasminogen activator in inflammatory cell recruitment and host defense against Pneumocystis carinii in mice.

Authors:  J M Beck; A M Preston; M R Gyetko
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

8.  Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.

Authors:  D J Webb; K S Thomas; S L Gonias
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

Review 9.  Microbial considerations in genetically engineered mouse research.

Authors:  Craig L Franklin
Journal:  ILAR J       Date:  2006
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.